Phosphorescence and fluorescence spectroscopy for detection of cancer and pre-cancer from normal/benign regions

The present application is directed to methods for detecting cancerous, pre-cancerous and benign/normal tissue using phosphorescence or the combination of fluorescence and phosphorescence emission from the tissue excited in 280 to 340 nm range. In particular, the application describes methods using...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ALIMOVA ALEKSANDRA, ALFANO ROBERT R, KATZ ALVIN
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ALIMOVA ALEKSANDRA
ALFANO ROBERT R
KATZ ALVIN
description The present application is directed to methods for detecting cancerous, pre-cancerous and benign/normal tissue using phosphorescence or the combination of fluorescence and phosphorescence emission from the tissue excited in 280 to 340 nm range. In particular, the application describes methods using a ratio of intensity of fluorescence emission to intensity of phosphorescence emission to provide a rapid cancer, pre-cancer and benign detection method. Normal human breast and prostate tissue, excited in 270 to 300 nm range, express the emission signatures at 340 nm, 440 nm and 500 nm. Cancerous tissue shows only minor emissions at 500 nm, thus the ratio of 340 nm peak to 500 nm peak emission intensities provides information about malignancy of a tissue. Fiber optic based instrumentation can be used to collect the luminescence signal from an area of a tissue less than 1 mm in diameter and using the described method can be screened to determine the state of the tissue sample taken. The combination of fiber optics and 2 D translation stage provides 2 D maps of intensity's ratio of the tissue surface and aids in localizing the malignancy region of the tissue.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2007083122A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2007083122A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2007083122A13</originalsourceid><addsrcrecordid>eNqNjTELwjAQhbs4iPofDpyLaTrYVURxFNS5xPTSFtJcuIuD_94gBVenx3t8H29Z0HUgiQMxisVgEUzowPnXb5CINjGJpfgGRwwdpryMFIAcWJMZ_lqRsZyrY5ogEE_G754Yxj4AY58VWRcLZ7zgZs5VsT2f7sdLiZFalGjyKab2cdNK7VVTV1ofqvo_6gOHnkR0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Phosphorescence and fluorescence spectroscopy for detection of cancer and pre-cancer from normal/benign regions</title><source>esp@cenet</source><creator>ALIMOVA ALEKSANDRA ; ALFANO ROBERT R ; KATZ ALVIN</creator><creatorcontrib>ALIMOVA ALEKSANDRA ; ALFANO ROBERT R ; KATZ ALVIN</creatorcontrib><description>The present application is directed to methods for detecting cancerous, pre-cancerous and benign/normal tissue using phosphorescence or the combination of fluorescence and phosphorescence emission from the tissue excited in 280 to 340 nm range. In particular, the application describes methods using a ratio of intensity of fluorescence emission to intensity of phosphorescence emission to provide a rapid cancer, pre-cancer and benign detection method. Normal human breast and prostate tissue, excited in 270 to 300 nm range, express the emission signatures at 340 nm, 440 nm and 500 nm. Cancerous tissue shows only minor emissions at 500 nm, thus the ratio of 340 nm peak to 500 nm peak emission intensities provides information about malignancy of a tissue. Fiber optic based instrumentation can be used to collect the luminescence signal from an area of a tissue less than 1 mm in diameter and using the described method can be screened to determine the state of the tissue sample taken. The combination of fiber optics and 2 D translation stage provides 2 D maps of intensity's ratio of the tissue surface and aids in localizing the malignancy region of the tissue.</description><language>eng</language><subject>DIAGNOSIS ; HUMAN NECESSITIES ; HYGIENE ; IDENTIFICATION ; MEDICAL OR VETERINARY SCIENCE ; SURGERY</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20070412&amp;DB=EPODOC&amp;CC=US&amp;NR=2007083122A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20070412&amp;DB=EPODOC&amp;CC=US&amp;NR=2007083122A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ALIMOVA ALEKSANDRA</creatorcontrib><creatorcontrib>ALFANO ROBERT R</creatorcontrib><creatorcontrib>KATZ ALVIN</creatorcontrib><title>Phosphorescence and fluorescence spectroscopy for detection of cancer and pre-cancer from normal/benign regions</title><description>The present application is directed to methods for detecting cancerous, pre-cancerous and benign/normal tissue using phosphorescence or the combination of fluorescence and phosphorescence emission from the tissue excited in 280 to 340 nm range. In particular, the application describes methods using a ratio of intensity of fluorescence emission to intensity of phosphorescence emission to provide a rapid cancer, pre-cancer and benign detection method. Normal human breast and prostate tissue, excited in 270 to 300 nm range, express the emission signatures at 340 nm, 440 nm and 500 nm. Cancerous tissue shows only minor emissions at 500 nm, thus the ratio of 340 nm peak to 500 nm peak emission intensities provides information about malignancy of a tissue. Fiber optic based instrumentation can be used to collect the luminescence signal from an area of a tissue less than 1 mm in diameter and using the described method can be screened to determine the state of the tissue sample taken. The combination of fiber optics and 2 D translation stage provides 2 D maps of intensity's ratio of the tissue surface and aids in localizing the malignancy region of the tissue.</description><subject>DIAGNOSIS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>IDENTIFICATION</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>SURGERY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjTELwjAQhbs4iPofDpyLaTrYVURxFNS5xPTSFtJcuIuD_94gBVenx3t8H29Z0HUgiQMxisVgEUzowPnXb5CINjGJpfgGRwwdpryMFIAcWJMZ_lqRsZyrY5ogEE_G754Yxj4AY58VWRcLZ7zgZs5VsT2f7sdLiZFalGjyKab2cdNK7VVTV1ofqvo_6gOHnkR0</recordid><startdate>20070412</startdate><enddate>20070412</enddate><creator>ALIMOVA ALEKSANDRA</creator><creator>ALFANO ROBERT R</creator><creator>KATZ ALVIN</creator><scope>EVB</scope></search><sort><creationdate>20070412</creationdate><title>Phosphorescence and fluorescence spectroscopy for detection of cancer and pre-cancer from normal/benign regions</title><author>ALIMOVA ALEKSANDRA ; ALFANO ROBERT R ; KATZ ALVIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2007083122A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>DIAGNOSIS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>IDENTIFICATION</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>SURGERY</topic><toplevel>online_resources</toplevel><creatorcontrib>ALIMOVA ALEKSANDRA</creatorcontrib><creatorcontrib>ALFANO ROBERT R</creatorcontrib><creatorcontrib>KATZ ALVIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ALIMOVA ALEKSANDRA</au><au>ALFANO ROBERT R</au><au>KATZ ALVIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Phosphorescence and fluorescence spectroscopy for detection of cancer and pre-cancer from normal/benign regions</title><date>2007-04-12</date><risdate>2007</risdate><abstract>The present application is directed to methods for detecting cancerous, pre-cancerous and benign/normal tissue using phosphorescence or the combination of fluorescence and phosphorescence emission from the tissue excited in 280 to 340 nm range. In particular, the application describes methods using a ratio of intensity of fluorescence emission to intensity of phosphorescence emission to provide a rapid cancer, pre-cancer and benign detection method. Normal human breast and prostate tissue, excited in 270 to 300 nm range, express the emission signatures at 340 nm, 440 nm and 500 nm. Cancerous tissue shows only minor emissions at 500 nm, thus the ratio of 340 nm peak to 500 nm peak emission intensities provides information about malignancy of a tissue. Fiber optic based instrumentation can be used to collect the luminescence signal from an area of a tissue less than 1 mm in diameter and using the described method can be screened to determine the state of the tissue sample taken. The combination of fiber optics and 2 D translation stage provides 2 D maps of intensity's ratio of the tissue surface and aids in localizing the malignancy region of the tissue.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2007083122A1
source esp@cenet
subjects DIAGNOSIS
HUMAN NECESSITIES
HYGIENE
IDENTIFICATION
MEDICAL OR VETERINARY SCIENCE
SURGERY
title Phosphorescence and fluorescence spectroscopy for detection of cancer and pre-cancer from normal/benign regions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T10%3A58%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ALIMOVA%20ALEKSANDRA&rft.date=2007-04-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2007083122A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true